The settlement resolves allegations that Teva paid Medicare patients’ cost sharing obligations for multiple sclerosis drug Copaxone while steadily raising the drug’s price, the announcement said.
Teva USA also agreed to resolve separate allegations that it conspired with other generic drug manufacturers to fix prices for pravastatin, a drug used to treat cholesterol and triglyceride levels, as well as two other generic drugs, the announcement said.
“Teva ...